|Articles|April 20, 2021
Liposomal and Nanoparticle Technology
Author(s)Pfizer CentreOne
Specializing in oncology, anti-infective and complex formulations, Pfizer CentreOne provides end to end services from development through to commercial manufacture of sterile dosage forms.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
2
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
3
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
4
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
5